Search Ontology:
ChEBI

EC 3.4.21.61 (kexin) inhibitor

Term ID
CHEBI:189665
Synonyms
  • andrenorphin-Gly-generating enzyme inhibitor
  • andrenorphin-Gly-generating enzyme inhibitors
  • EC 3.4.21.61 (kexin) inhibitors
  • EC 3.4.21.61 inhibitor
  • EC 3.4.21.61 inhibitors
  • endoproteinase Kex2p inhibitor
  • endoproteinase Kex2p inhibitors
  • gene KEX2 dibasic proteinase inhibitor
  • gene KEX2 dibasic proteinase inhibitors
  • Kex 2p proteinase inhibitor
  • Kex 2p proteinase inhibitors
  • Kex2 endopeptidase inhibitor
  • Kex2 endopeptidase inhibitors
  • Kex2 endoprotease inhibitor
  • Kex2 endoprotease inhibitors
  • Kex2 endoproteinase inhibitor
  • Kex2 endoproteinase inhibitors
  • Kex2 protease inhibitor
  • Kex2 protease inhibitors
  • Kex2 proteinase inhibitor
  • Kex2 proteinase inhibitors
  • Kex2-like endoproteinase inhibitor
  • Kex2-like endoproteinase inhibitors
  • Kex2-like precursor protein processing endoprotease inhibitor
  • Kex2-like precursor protein processing endoprotease inhibitors
  • kexin inhibitor
  • kexin inhibitors
  • paired-basic endopeptidase inhibitor
  • paired-basic endopeptidase inhibitors
  • prohormone-processing endoprotease inhibitor
  • prohormone-processing endoprotease inhibitors
  • prohormone-processing KEX2 proteinase inhibitor
  • prohormone-processing KEX2 proteinase inhibitors
  • prohormone-processing proteinase inhibitor
  • prohormone-processing proteinase inhibitors
  • protease KEX2 inhibitor
  • protease KEX2 inhibitors
  • proteinase Kex2p inhibitor
  • proteinase Kex2p inhibitors
  • proteinase yscF inhibitor
  • proteinase yscF inhibitors
  • yeast KEX2 protease inhibitor
  • yeast KEX2 protease inhibitors
Definition
An EC 3.4.21.* (serine endopeptidase) inhibitor that interferes with the action of kexin (EC 3.4.21.61).
References
Ontology
ChEBI  ( EBI )
Relationships
is a type of
inverse has_role
Phenotype
Phenotype resulting from EC 3.4.21.61 (kexin) inhibitor
Phenotype where environments contain EC 3.4.21.61 (kexin) inhibitor
Phenotype modified by environments containing EC 3.4.21.61 (kexin) inhibitor
Human Disease Model